Cash figures as of 2026-04-30. Database snapshot: 2026-09-21.
Price history
Loading PMCB daily closes…
Loading price history…
Pipeline assets
CypCaps
Preclinical · ActiveModality: cell encapsulation
Partnerships SG Austria (relationship under board review; all licensed patents expired)
Indications
Locally advanced pancreatic cancer(Preclinical)
Status note Cell-in-a-Box encapsulated-cell therapy for LAPC. IND submitted Sep 2020; FDA placed clinical hold Oct 2020 (manufacturing/preclinical deficiencies). Company submitted responses addressing hold; Board reviewing whether to continue SG Austria-dependent programs — could result in delay or termination. Cellulose-based live cell encapsulation (Cell-in-a-Box platform).
Per-asset detail extracted from the 10-Q filed 2026-09-14. Fields the filing does not state are marked "not disclosed" rather than filled from other sources.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
No specialist-fund holders in 13F data for this company.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.